NCT06053528

Brief Summary

The objective of this study is to determine the pattern and outcome of respiratory diseases in adults patients admitted to the Department of Chest Diseases at Assiut University Hospital.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 25, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

1 year

First QC Date

September 1, 2023

Last Update Submit

September 22, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Determine number of patients who experience improvement on discharge

    One year

  • Number of patient who Transferred to another hospital forcontintreatment

    One year

  • Number of patient died while on admission

    One year

  • Number of patient who Discharged against medical advice

    One year

Interventions

Effect if treatment

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Prospective, descriptive and analytical study.

You may qualify if:

  • All adults patients admitted to the Chest Department during the study period will be included.

You may not qualify if:

  • Patients who will die, be discharged, or be transferred before completing data collection will be excluded from our study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Anti-Bacterial Agents

Intervention Hierarchy (Ancestors)

Anti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Central Study Contacts

Fatma Hamdan Zaki, Resident doctor

CONTACT

Amany Omar, Professor of Chest Disease

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

September 1, 2023

First Posted

September 25, 2023

Study Start

October 1, 2023

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

September 25, 2023

Record last verified: 2023-09